Sir Greg Winter co-founds new biotechnology company

Wednesday 7 October 2009

Sir Greg Winter, a founder of both Cambridge Antibody Technology and Domantis, has put his scientific and entrepreneurial skills to work again as the scientific co-founder of new company in the UK that is developing mini-antibodies.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom